Sakai Chemical Industry Co., Ltd. (TYO:4078)
Japan · Delayed Price · Currency is JPY 3,535.00
+30.00 (0.86%)
At close: Feb 6, 2026
Sakai Chemical Industry Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| 82,594 | 84,409 | 82,105 | 83,861 | 80,135 | 84,918 | |
Revenue Growth (YoY) | -1.44% | 2.81% | -2.09% | 4.65% | -5.63% | -2.59% |
Cost of Revenue | 61,611 | 64,127 | 65,248 | 65,381 | 59,090 | 67,696 |
Gross Profit | 20,983 | 20,282 | 16,857 | 18,480 | 21,045 | 17,222 |
Selling, General & Admin | 14,119 | 14,077 | 13,789 | 13,936 | 13,416 | 12,918 |
Amortization of Goodwill & Intangibles | 111 | 111 | 125 | 136 | 134 | - |
Operating Expenses | 14,230 | 14,188 | 13,914 | 14,072 | 13,550 | 12,918 |
Operating Income | 6,753 | 6,094 | 2,943 | 4,408 | 7,495 | 4,304 |
Interest Expense | -155 | -140 | -116 | -76 | -73 | -89 |
Interest & Investment Income | 225 | 203 | 161 | 151 | 227 | 239 |
Currency Exchange Gain (Loss) | 85 | 32 | 311 | 363 | 389 | -59 |
Other Non Operating Income (Expenses) | 6 | 88 | -233 | 7 | 802 | -383 |
EBT Excluding Unusual Items | 6,914 | 6,277 | 3,066 | 4,853 | 8,840 | 4,012 |
Gain (Loss) on Sale of Investments | 269 | 319 | 66 | 4 | 1,261 | 1,336 |
Gain (Loss) on Sale of Assets | 1,174 | 2 | - | 123 | 30 | - |
Asset Writedown | -454 | -626 | -6,835 | -167 | -613 | -7,373 |
Other Unusual Items | - | -1 | -1 | 163 | -295 | -13 |
Pretax Income | 7,903 | 5,971 | -3,704 | 4,976 | 9,223 | -2,038 |
Income Tax Expense | 1,590 | 824 | 3,091 | 2,368 | 2,119 | 422 |
Earnings From Continuing Operations | 6,313 | 5,147 | -6,795 | 2,608 | 7,104 | -2,460 |
Minority Interest in Earnings | -120 | -134 | -297 | -264 | -357 | -343 |
Net Income | 6,193 | 5,013 | -7,092 | 2,344 | 6,747 | -2,803 |
Net Income to Common | 6,193 | 5,013 | -7,092 | 2,344 | 6,747 | -2,803 |
Net Income Growth | - | - | - | -65.26% | - | - |
Shares Outstanding (Basic) | 16 | 16 | 16 | 16 | 17 | 17 |
Shares Outstanding (Diluted) | 18 | 18 | 16 | 16 | 17 | 17 |
Shares Change (YoY) | 9.91% | 10.93% | 0.11% | -2.34% | -1.52% | 0.11% |
EPS (Basic) | 386.31 | 309.16 | -437.64 | 144.81 | 407.06 | -166.55 |
EPS (Diluted) | 347.56 | 278.91 | -437.64 | 144.81 | 407.06 | -166.55 |
EPS Growth | - | - | - | -64.43% | - | - |
Free Cash Flow | 3,405 | 5,057 | 2,842 | -1,885 | 1,503 | -1,741 |
Free Cash Flow Per Share | 191.09 | 281.32 | 175.38 | -116.45 | 90.68 | -103.45 |
Dividend Per Share | 137.500 | 135.000 | 70.000 | 75.000 | 70.000 | 15.000 |
Dividend Growth | 41.03% | 92.86% | -6.67% | 7.14% | 366.67% | -62.50% |
Gross Margin | 25.41% | 24.03% | 20.53% | 22.04% | 26.26% | 20.28% |
Operating Margin | 8.18% | 7.22% | 3.58% | 5.26% | 9.35% | 5.07% |
Profit Margin | 7.50% | 5.94% | -8.64% | 2.79% | 8.42% | -3.30% |
Free Cash Flow Margin | 4.12% | 5.99% | 3.46% | -2.25% | 1.88% | -2.05% |
EBITDA | 10,423 | 9,743 | 7,297 | 8,825 | 11,828 | 8,547 |
EBITDA Margin | 12.62% | 11.54% | 8.89% | 10.52% | 14.76% | 10.06% |
D&A For EBITDA | 3,670 | 3,649 | 4,354 | 4,417 | 4,333 | 4,243 |
EBIT | 6,753 | 6,094 | 2,943 | 4,408 | 7,495 | 4,304 |
EBIT Margin | 8.18% | 7.22% | 3.58% | 5.26% | 9.35% | 5.07% |
Effective Tax Rate | 20.12% | 13.80% | - | 47.59% | 22.98% | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.